<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pharmjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Разработка и регистрация лекарственных средств</journal-title><trans-title-group xml:lang="en"><trans-title>Drug development &amp; registration</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2305-2066</issn><issn pub-type="epub">2658-5049</issn><publisher><publisher-name>LLC «CPHA»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pharmjournal-1412</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОТ РЕДАКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FROM EDITOR</subject></subj-group></article-categories><title-group><article-title>О Пермском центре кластерного развития фармацевтической отрасли «ПАРМА»</article-title><trans-title-group xml:lang="en"><trans-title>About the Perm Cluster Development Center pharmaceutical industry "PARMA"</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editorial</surname><given-names>Article</given-names></name></name-alternatives></contrib></contrib-group><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>28</day><month>12</month><year>2022</year></pub-date><volume>11</volume><issue>4</issue><issue-title>Приложение 1</issue-title><fpage>10</fpage><lpage>12</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editorial a.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmjournal.ru/jour/article/view/1412">https://www.pharmjournal.ru/jour/article/view/1412</self-uri><abstract><p>9 ноября 2022 года между Правительством Пермского края, ФГБОУ ВО Пермская государственная фармацевтичсекая академия Минздрава России (далее – ПГФА) и Автономной некоммерческой организацией «Пермский научно-образовательный центр мирового уровня «Рациональное недропользование» (далее – Пермский НОЦ) заключено Соглашение о создании Пермского центра кластерного развития фармацевтической отрасли «ПАРМА» (далее – ЦКР ПАРМА). Цель Соглашения создание материально-технической, научно-технологической и интеллектуальной среды, обеспечивающей оказание широкого спектра образовательных и научных услуг в рамках функционирования полного цикла жизни фармацевтической продукции (от разработки до реализации).</p></abstract><trans-abstract xml:lang="en"><p>On November 9, 2022, between the Government of the Perm Territory, the Perm State Pharmaceutical Academy of the Ministry of Health of Russia (hereinafter referred to as PGFA) and the Autonomous Non-Profit Organization "Perm Scientific and Educational Center of the World Level "Rational Subsoil Use" (hereinafter referred to as the Perm REC) signed an Agreement on the establishment of the Perm Center cluster development of the pharmaceutical industry "PARMA" (hereinafter - CKR PARMA). The purpose of the Agreement is to create a material and technical, scientific, technological and intellectual environment that ensures the provision of a wide range of educational and scientific services within the framework of the full life cycle of pharmaceutical products (from development to sales).</p></trans-abstract></article-meta></front><back><ref-list><title>References</title></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
